Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-21-003648
Filing Date
2021-03-25
Accepted
2021-03-25 17:30:08
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 33225
2 filename2.txt TEXT-EXTRACT 8917
  Complete submission text file 0000000000-21-003648.txt   55296
Mailing Address 201 E. JEFFERSON ST., SUITE 110B LOUISVILLE KY 40202
Business Address 201 E. JEFFERSON ST., SUITE 110B LOUISVILLE KY 40202 502-569-1059
Talaris Therapeutics, Inc. (Filed for) CIK: 0001827506 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: UPLOAD
SIC: 2836 Biological Products, (No Diagnostic Substances)